Results 21 to 30 of about 112,825,263 (146)

Renal cells activate the platelet receptor CLEC-2 through podoplanin.

open access: yes, 2008
We have recently shown that the C-type lectin-like receptor, CLEC-2, is expressed on platelets and that it mediates powerful platelet aggregation by the snake venom toxin rhodocytin.
Christou, Charita M   +9 more
core   +9 more sources

Development of ligands for the platelet receptor CLEC-2

open access: yes, 2022
Platelets are anucleate cells derived from megakaryocytes, which play an important role in the regulation of haemostasis and thrombosis at the injury site; however, they are also involved in other physiological processes such as inflammation, during ...
Morán Lara, Luis Arturo
core   +2 more sources

CLEC-2 and podoplanin, partners again [PDF]

open access: yesBlood, 2016
In this issue of Blood, Tamura et al reveal a novel function for podoplanin on periarteriolar stromal cells in the bone marrow: promoting megakaryocyte growth and proplatelet formation by interaction with C-type lectin-like receptor 2 (CLEC-2).
Jianxin Fu, Lijun Xia
openaire   +2 more sources

CLEC-2 and CD177 have a profound effect on the CAF phosphoproteome.

open access: yes, 2021
(A) Density plots depicting the changes observed in phosphorylated residues (x-axis) versus total protein abundance changes (y-axis), for the 70% protein overlapping proteins between both assays, in all four conditions.
Victoria C. Pham (7388111)   +13 more
core   +2 more sources

Characterisation of platelet receptor CLEC-2 in thrombosis and inflammation [PDF]

open access: yes, 2022
Platelets have an established role in thrombosis and haemostasis. C-type lectin-like receptor 2 (CLEC-2) is highly expressed on platelets and a subpopulation of myeloid cells, and is critical in lymphatic development.
Bourne, Joshua Henry
core   +5 more sources

Association of C-type lectin-like receptor 2 and galectin-1 with portal vein system thrombosis in HBV-related liver cirrhosis

open access: yesFrontiers in Medicine, 2023
Background and aimsHepatitis B virus (HBV) infection is the most common cause of liver cirrhosis. Portal venous system thrombosis (PVST) is a major complication of liver cirrhosis.
Yiyan Zhang   +12 more
doaj   +1 more source

GPVI and CLEC‐2 in hemostasis and vascular integrity [PDF]

open access: yesJournal of Thrombosis and Haemostasis, 2010
The glycoprotein VI (GPVI)-FcR gamma-chain complex initiates powerful activation of platelets by the subendothelial matrix proteins collagen and laminin through an immunoreceptor tyrosine-based activation motif (ITAM)-regulated signaling pathway. ITAMs are characterized by two YxxL sequences separated by 6-12 amino acids and are found associated with ...
S P, Watson   +2 more
openaire   +2 more sources

CLEC-2 Prevents Accumulation and Retention of Inflammatory Macrophages During Murine Peritonitis

open access: yesFrontiers in Immunology, 2021
Platelets play a key role in the development, progression and resolution of the inflammatory response during sterile inflammation and infection, although the mechanism is not well understood.
Joshua H. Bourne   +19 more
doaj   +1 more source

Quantitative single molecule analysis of podoplanin clustering in fibroblastic reticular cells uncovers CD44 function

open access: yesOpen Biology, 2023
Upon initial immune challenge, dendritic cells (DCs) migrate to lymph nodes and interact with fibroblastic reticular cells (FRCs) via C-type lectin-like receptor 2 (CLEC-2).
Shu En Lim   +4 more
doaj   +1 more source

CLEC-2: the inside story [PDF]

open access: yesBlood, 2015
Excessive platelet aggregation at sites of atherosclerotic plaque rupture can result in formation of pathological thrombi that reduce or obstruct blood flow to downstream tissues and cause tissue ischemia or infarction.2 Consequently, antiplatelet drugs have been developed for treatment of acute thrombotic events. Platelet activation and aggregation at
openaire   +2 more sources

Home - About - Disclaimer - Privacy